Skip to main content
. 2019 Apr 16;7:247. doi: 10.3389/fchem.2019.00247

Table 1.

Anti-RSV activity of 5,6-dichloro-1-phenyl-benzotriazole amides (5a–d and 7a–h), 5,6-dichloro-2-phenyl-benzotriazole amides (6a–h and 8a–h), and 5,6-dichloro-2-phenyl-benzotriazole ureas (10a–k).

Comp. Vero-76 cells RSV Comp. Vero-76 cells RSV
a CC50 bEC50 aCC50 bEC50
1a >100 20 8a >100 >100
5a 30 3 8b >100 27
5b 30 4 8c >100 >100
5c 10 4 8d 80 3
5d 20 >30 8e >100 33
7a >100 60 8f 80 20
7b >100 >100 8g >100 50
7c >100 35 8h >100 60
7d 90 5 10a >100 >100
7e >100 13 10b 30 3
7f >100 8 10c >100 >100
7g 9 5 10d 90 2
7h >100 11 10e >100 >100
1b >100 6 10f >100 >100
6a >100 >100 10g >100 >100
6b >100 >100 10h >100 >100
6c >100 >100 10i >100 >100
6d >100 40 10j >100 >100
6e >100 6 10k >100 >100
6f >100 6 ribavirin >100 7
6-azauridine ≥14 1.4

Ribavirin and 6-azauridine were used as reference inhibitors. Data represent mean values from three independent determinations; variation among duplicate samples was <15%.

a

Compound concentration (μM) required to reduce the viability of mock-infected VERO-76 cells by 50%. as determined by the MTT method after 5 days.

b

Compound concentration (μM) required to reduce the plaque number of RSV by 50% in VERO-76 monolayers. The most interesting results are in bold.